Mannkind implodes as drug indexes sag
January 20, 2011 at 10:57 AM EST
Shares of Mannkind are sinking on news that the FDA has rejected its inhaled insulin product Afrezza for the second time.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.